Ending 2025 Together: Building the Future of Hemostasis Today – and It’s Just the Beginning

From the Start: May 2025 to Today

From the very beginning, Hemostasis Today was founded with a clear purpose: to be the daily voice of hemostasis and thrombosis.

Our vision has always been to become the fastest, most reliable, and most innovative global source of information in coagulation science — supporting a future in which bleeding and clotting disorders are better understood, more effectively treated, and ultimately conquered.

Since launching in May 2025, Hemostasis Today has continued steadily along this path. What began as a focused initiative has grown into a dynamic platform followed by more than 5,500 professionals on LinkedIn, reflecting both the urgency and the innovation that define the field. With each update, article, and insight, we remain committed to accuracy, relevance, and impact as our global community continues to grow. Along the way, we’ve shared over 4,300 posts — each one part of an ongoing conversation shaped by research, clinical practice, and the people behind the science. Every post has been part of a shared effort to stay informed, celebrate innovation, and grow together as a community dedicated to advancing hemostasis and thrombosis care.

Covering the Moments That Matter: Global Conferences

A key part of our growth this year has been our coverage of major international conferences, bringing timely updates and insights beyond the conference halls.

Through dedicated coverage, highlights, and expert perspectives, we aimed to extend the reach of these meetings — connecting new data, discussions, and emerging trends to a broader audience who could not always be present in person.

Starting with The European Hematology Association (EHA) Congress 2025, that officially took place in Milan from June 12 to 15, bringing together hematology professionals from around the world to share the latest research, clinical advances, and innovations shaping the future of hematologic care.

10 Posts Not to Miss from EHA 2025

EHA 2025 meeting also celebrated the 30th edition of the EHA Congress, a milestone reflecting three decades of scientific excellence, global collaboration, and commitment to improving outcomes for patients with blood disorders.

25 Posts Not to Miss from EHA 2025

Beyond the scientific program, EHA 2025 fostered meaningful dialogue across the field. Voices such as Nico Gagelmann, Young National Society Ambassador at the European Hematology Association and Chair of the CAR-T for plasma cell disorder committee at European Society for Blood and Marrow Transplantation, shared key reflections and insights through a series of posts following the congress — extending the impact of EHA 2025 well beyond the meeting itself. Hemostasis Today collected 7 Posts Not to Miss From the EHA 2025 by Nico Gagelmann, which you can read here.

Following EHA, the ISTH Congress 2025 was held from June 21 to 25, bringing together thousands of experts in thrombosis, hemostasis, and vascular biology from around the world. Hosted by the International Society on Thrombosis and Haemostasis, the congress once again served as a leading global forum for advancing research, clinical practice, and education in blood-related disorders.

20 Posts Not To Miss From ISTH 2025

Closing the Year at the Center of Hematology: ASH 2025

As the year drew to a close, the global hematology community came together for the American Society of Hematology Congress 2025 (ASH25), held in Orlando, Florida, from December 6 to 9. The meeting once again served as one of the most influential gatherings in hematology, bringing together professionals from across the world to share knowledge, data, and perspectives shaping the future of patient care.

Over the course of 4 intensive days, Hemostasis Today followed ASH 2025 day by day, capturing the most important moments as they unfolded. We highlighted key sessions, emerging themes, and the voices of field leaders who are driving progress in hematology.

Don’t Miss The Highlights: ASH25 Day 1

Don’t Miss The Highlights: ASH25 Day 2

Don’t Miss The Highlights: ASH25 Day 3

Don’t Miss The Highlights: ASH25 Day 4

Through dedicated coverage, curated highlights, and expert perspectives, Hemostasis Today amplified the voices of field leaders who are actively driving progress in hematology. Our goal throughout ASH 2025 was not only to report what happened, but to help contextualize what truly matters. A key part of this approach was spotlighting expert-led content that guided readers through the most relevant moments of the congress. Among these was “12 Posts Not to Miss From ASH 2025” by Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital and Head of the Department of Haemostaseology and the Hemophilia Center at Medical Clinic 2. With a career dedicated to inherited and acquired coagulation disorders — particularly hemophilia and related conditions — his insights offered a focused and authoritative lens on the most impactful developments presented during the meeting. You may also find interesting Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders and for TTP and Thrombosis from ASH 2025, collected by Hemostasis Today.

We also highlighted “8 Posts Not to Miss From ASH 2025” by Marc Carrier, a prominent hematologist, Professor at the University of Ottawa, and Senior Scientist at The Ottawa Hospital Research Institute, widely recognized for his work in venous thromboembolic disease and cancer-associated thrombosis. By highlighting these expert-curated perspectives, Hemostasis Today helped carry the most important insights from ASH 2025 beyond the meeting itself — encouraging ongoing discussion, reflection, and progress across the hematology and hemostasis community.

Through dedicated coverage, highlights, and expert perspectives, we aimed to extend the reach of these meetings — connecting new data, discussions, and emerging trends to a broader audience who could not always be present in person.

Expanding Our Reach: The Hemostasis Today Newsletter

In November 2025, we launched the Hemostasis Today Newsletter, extending our mission beyond daily posts and into readers’ inboxes with carefully curated insights from across the field.

The first edition was released on November 7, marking an important new chapter in how we connect with our audience. Since then, the newsletter has grown to nearly 3000 subscribers, highlighting a clear demand for concise, reliable, and high-quality updates in hemostasis.

Insights on Rebalancing Agents in Hemophilia from Cédric Hermans and Quentin Van Thillo

Rebalancing agents represent a paradigm shift in hemophilia care, moving beyond traditional factor replacement toward therapies that restore hemostatic balance by targeting natural anticoagulant pathways. Insights from experts such as Cédric Hermans and Quentin Van Thillo are particularly valuable as they help translate a rapidly evolving therapeutic landscape into practical clinical understanding. By exploring these insights in the first editon of Hemostasis Today Newsletter, we support informed decision-making and ongoing dialogue at a moment when hemophilia treatment is entering a new and transformative phase.

Our newsletter became another meaningful step toward building a trusted, sustainable information space for healthcare professionals and researchers worldwide. We believe that collaboration and knowledge-sharing drive progress, and our Newsletter is more than just a new format, it’s a space where professionals and researchers can stay informed, connected, and inspired.

A Milestone Moment: Our First Original Article

And last but not least, as we close the year, Hemostasis Today marked another important milestone with the publication of our first original article, “Oncology vs Hematology: Why They Often Go Together”

Hematology and oncology appear to occupy separate intellectual territories: one rooted in the physiology of blood and marrow, the other organized around solid tumors and organ-based disease. This distinction gives rise to a perceived “hematology vs oncology” dichotomy.

This review smoothly sets up the “vs” while exploring the “together”, and briefly dives into the traditional scope, history, rationale, and overarching challenges. Is hematology the same as oncology? Are hematologists also oncologists? Is hematology part of oncology? Who is a hemato-oncologist? – Answers to all these questions, and many more, can be found in our article written by Susanna Mikayelyan, MD.

Looking Ahead

Ending 2025 together is not a conclusion — it is a foundation.

From our launch in May to where we stand today, Hemostasis Today has grown thanks to the people around it. We want to sincerely thank everyone who has taken the time to read, follow, share, contribute, and support our work — researchers, clinicians, partners, collaborators, and members of our community around the world.

Your engagement, curiosity, and trust continue to shape what Hemostasis Today is becoming. As we move into the next year, our commitment remains the same:

to inform, connect, and fuel the future of bleeding and clotting care — together.